Literature DB >> 15987733

Angiotensin II induces apoptosis in vivo in skeletal, as well as cardiac, muscle of the rat.

Jatin G Burniston1, Amarjit Saini, Lip-Bun Tan, David F Goldspink.   

Abstract

Our previous work has established that angiotensin II is cardiotoxic. Here we sought to investigate whether skeletal muscle is similarly susceptible to damage. Male Wistar rats were either given a single subcutaneous injection of angiotensin II (range 1 microg kg-1 to 10 mg kg-1) or only the vehicle and killed 7 h later, or implanted with preconditioned osmotic pumps dispensing 1 mg kg-1 day-1 angiotensin II and killed 9 or 18 h later. Apoptotic (caspase 3 positive) myocytes were counted on cryosections of the heart, soleus, tibialis anterior and diaphragm muscle. Single injections of 100 microg kg-1 to 10 mg kg-1 angiotensin II induced significant (P<0.05) myocyte apoptosis (per 10(4) viable myocytes) in the heart and this was heterogeneously distributed, peaking (5.7+/-0.6; P<0.05) at a point 6 mm from the apex, i.e. approximately three-quarters of the way towards the base. The slow-twitch soleus muscle was also damaged significantly (peak=2.6+/-0.4; P<0.05), while only the administration of 1 mg kg-1 induced significant (P<0.05) apoptosis in the fast-twitch tibialis anterior muscle (peak=1.2+/-0.3). Infusion of 1 mg kg-1 day-1 angiotensin II induced more myocyte apoptosis than a single bolus administration of the same dose, and in general there was a higher incidence of apoptosis in muscles harvested after 18 than after 9 h. Infusion of 1 mg kg-1 day-1 angiotensin II over 18 h induced significant (P<0.05) myocyte apoptosis in the heart (3.3+/-0.4), soleus (3.9+/-1), tibialis anterior (5.9+/-0.4) and diaphragm (19.8+/-5.6) muscle. Depending on the muscle type, angiotensin II induces myocyte apoptosis in skeletal muscle to a similar or greater extent as in cardiac muscle, supporting the hypothesis that angiotensin II is generally toxic to all striated muscles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987733     DOI: 10.1113/expphysiol.2005.030908

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  13 in total

Review 1.  Angiotensin receptor blockers and tumorigenesis: something to be (or not to be) concerned about?

Authors:  Vadim Tchaikovski; Gregory Y H Lip
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

2.  Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice.

Authors:  Ping Li; Richard E Waters; Shelley I Redfern; Mei Zhang; Lan Mao; Brian H Annex; Zhen Yan
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  Angiotensin II and oxidative stress in the failing heart.

Authors:  Daniela Zablocki; Junichi Sadoshima
Journal:  Antioxid Redox Signal       Date:  2012-05-03       Impact factor: 8.401

4.  Mineralocorticoid receptor antagonism prevents hedonic deficits induced by a chronic sodium appetite.

Authors:  Michael J Morris; Elisa S Na; Alan Kim Johnson
Journal:  Behav Neurosci       Date:  2010-04       Impact factor: 1.912

5.  Distinct muscle apoptotic pathways are activated in muscles with different fiber types in a rat model of critical illness myopathy.

Authors:  Benjamin T Barnes; Amy L Confides; Mark M Rich; Esther E Dupont-Versteegden
Journal:  J Muscle Res Cell Motil       Date:  2015-03-05       Impact factor: 2.698

Review 6.  Renin-Angiotensin System Inhibitors to Mitigate Cancer Treatment-Related Adverse Events.

Authors:  Matthias Pinter; Wilhelmus J Kwanten; Rakesh K Jain
Journal:  Clin Cancer Res       Date:  2018-04-02       Impact factor: 12.531

7.  Relative myotoxic and haemodynamic effects of the beta-agonists fenoterol and clenbuterol measured in conscious unrestrained rats.

Authors:  Jatin G Burniston; Lip-Bun Tan; David F Goldspink
Journal:  Exp Physiol       Date:  2006-09-14       Impact factor: 2.969

8.  Exploring metabolic dysfunction in chronic kidney disease.

Authors:  Adrian D Slee
Journal:  Nutr Metab (Lond)       Date:  2012-04-26       Impact factor: 4.169

Review 9.  Knocking out angiotensin II in the heart.

Authors:  Daniela Zablocki; Junichi Sadoshima
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

10.  Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection.

Authors:  Jiancheng Xu; Guanjun Wang; Yuehui Wang; Qiuju Liu; Wei Xu; Yi Tan; Lu Cai
Journal:  J Cell Mol Med       Date:  2009-07-06       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.